Sterling Capital Management LLC Hille Vax, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 87 shares of HLVX stock, worth $167. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87Holding current value
$167% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HLVX
# of Institutions
93Shares Held
39.4MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$20.5 Million9.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4MShares$7.73 Million1.22% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.48MShares$6.72 Million0.03% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$4.03 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.96MShares$3.78 Million0.0% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $64.5M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.